Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in RZLT — Rezolute, Inc.

CIK 1390777 NEW YORK, NY
Back to RZLT Full portfolio

Position in RZLT

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$1,103,803
+$524,980 QoQ
Shares Held
212,270
+11.9% QoQ
Ownership
0.220%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 144 holders
Holding Since
Jun 2022
12 quarters on record
Voting authority Sole 81% Shared 0% None 19%

Common Shares in RZLT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. RZLT ranks #190 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in RZLT

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,103,803 212,270
2026-03-31 $578,823 189,779
2025-12-31 $1,585,190 671,692
2025-09-30 $1,797,853 191,261
2025-06-30 $627,819 140,767
2023-12-31 $26,798 26,988
2023-09-30 $35,623 26,988
2023-06-30 $53,435 26,988
2023-03-31 $51,816 26,988
2022-12-31 $55,864 26,988
2022-09-30 $71,886 26,236
2022-06-30 $88,020 27,251